Specialty OB/GYN
-
Featured
YAP1 Oncogene Synergizes with HPV to Promote Cervical Cancer
Researchers have provided in vitro and in vivo evidence that the YAP1 oncogene can induce cervical cancer regardless of HPV infection. Further, the synergism between HPV and YAP1 significantly accelerates the development of cervical cancer and HPV vaccination remains vitally important.
-
Fertility Treatment Innovations Address Care Amid COVID-19
The Massachusetts General Hospital Fertility Center is innovating treatment with virtual visits and consultations, building on modifications that provided continuity and engagement during the COVID-19 pandemic.
-
Percutaneous Valve Replacement Therapy Sometimes an Option During Pregnancy
According to Massachusetts General Hospital clincians, percutaneous balloon mitral valvuloplasty is now the treatment of choice when mitral valve repair is indicated during pregnancy, and catheter-based procedures are being tried for treatment of aortic stenosis in pregnant women.
-
Review: Modifications in Obstetric Care During Viral Pandemics
An evidence-based review discusses how to modify obstetric care in the face of pandemic-related constraints on personnel and resources.
OB/GYN contributors
-
Amanda Ramos, MD
Fellow, Gynecologic Oncology
Recent Article
Combination Immunotherapy May Be the Best Treatment for Certain Uterine Cancers
-
Andrea Edlow, MD, MSc
Maternal-Fetal Medicine Specialist , Investigator, Vincent Center for Reproductive Biology
Recent Article
Composition of Maternal Diet Influences Fetal Brain Gene Expression and Offspring Behavior in Mice
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
Study Examines the Prevalence of COVID-19 Infections in Pregnant Women About to Give Birth
-
Irene C. Souter, MD
Director, Preimplantation Genetic Diagnostics Program, Physician, Fertility Center
Recent Article
Male Factor Infertility Does Not Affect Duration of Pre-Implantation Embryo Development, But May Affect Usability -
Jeffrey L. Ecker, MD
Chief, Department of Obstetrics & Gynecology
Recent Article
Confronting the Opioid Epidemic in the OB/GYN Practice: Optimizing Prescribing Habits and Reducing Opioid Misuse
-
John Petrozza, MD
Chief, Division of Reproductive Medicine and IVF, Director, Massachusetts General Fertility Center, Co-director, Integrated Fibroid Program
Recent Article
Fertility Treatment Innovations Address Care Amid COVID-19 -
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization, Gynecologic Oncologist, Center for Gynecologic Oncology
Recent Article
Editorial: It's Time to Study "Hospital at Home" After Surgery
-
Marie Henderson, CNM, MSN
Nurse-Midwife
Recent Article
New Departmental Protocol Substantially Reduces Post-Cesarean Opioid Prescribing
-
Mary E. Sabatini, MD, PhD
Medical Director, Clinic for Reproductive Health and Cancer, Medical Director, Third Party Reproduction
Recent Article
The Müllerian Inhibiting Substance: Changing the Fertility Landscape for Young Women with Cancer
-
May M. Wakamatsu, MD
Director, Female Pelvic Medicine & Reconstructive Surgery, Vice Chair, Gynecology
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Milena M. Weinstein, MD
Director of Research, Female Pelvic Medicine and Reconstructive Surgery Fellowship, Co-director, Center for Pelvic Floor Disorders
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Sarah N. Bernstein, MD
Maternal Fetal Medicine Specialist, Medical director, Outpatient Obstetrics Program
Recent Article
Managing the Cardiovascular Complications of Substance Use Disorders During Pregnancy
-
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Recent Article
Developing Precision Therapies for Ovarian Cancer
-
William H. Barth, MD
Vice Chair, Obstetrics
Recent Article
Percutaneous Valve Replacement Therapy Sometimes an Option During Pregnancy
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.
